Adial Pharmaceuticals (ADIL) Share-based Compensation (2017 - 2026)
Adial Pharmaceuticals (ADIL) posted Share-based Compensation of $137,100 for Q2 2026, up 10.3% from $124,269 a year earlier but down 7.3% from the prior quarter.
Powered by 
Analysis
Adial Pharmaceuticals (ADIL) Share-based Compensation (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Adial Pharmaceuticals was $600,200, down 17.7% year-over-year; for FY2025, it was $676,200, down 15.1% from FY2024.
- Annual Share-based Compensation has declined for four consecutive years, with a five-year compound annual growth rate of -19.6% (FY2020 to FY2025).
- In prior years, Adial Pharmaceuticals' Share-based Compensation was $796,831 in FY2024 (-54.4%), $1.75 million in FY2023 (-48.2%), $3.37 million in FY2022 (-20.4%) and $4.24 million in FY2021 (+110.5%).
- Quarterly Share-based Compensation has run from a low of $108,750 in Q2 2023 to a high of $1.19 million in Q3 2021 over five years.
- On a year-over-year basis, Share-based Compensation increased in three of the last eight quarters, with an average decline of 6.5%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2021, with growth of 138.7%; the weakest was Q2 2023, with a decline of 90.1%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $147,900 (Q1 2026), $168,036 (Q4 2025) and $147,164 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Adial Pharmaceuticals | 19.71 Mn | -24.07 Mn | - | 137,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 137,000.00 |
| Mar 31, 2026 | 86,000.00 |
| Dec 31, 2025 | 168,036.00 |
| Sep 30, 2025 | 147,334.00 |
| Jun 30, 2025 | 124,000.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | 180,202.00 |
| Sep 30, 2024 | 188,261.00 |
| Jun 30, 2024 | 153,391.00 |
| Mar 31, 2024 | 177,003.00 |
| Dec 31, 2023 | 280,847.00 |
| Sep 30, 2023 | 293,665.00 |
| Jun 30, 2023 | 427,317.00 |
| Mar 31, 2023 | 397,442.00 |
| Dec 31, 2022 | 734,144.00 |
| Sep 30, 2022 | 557,015.00 |
| Jun 30, 2022 | 625,816.00 |
| Mar 31, 2022 | 567,189.00 |
| Dec 31, 2021 | 883,558.00 |
| Sep 30, 2021 | 1.19 Mn |
API Access
Adial Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ADIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ADIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ADIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();